Vaping for weight control: A cross-sectional population study in England.

Authors:
Jackson SE; Brown J; Aveyard P; Dobbie F; Uny I and 2 more

Journal:
Addict Behav

Publication Year: 2019

DOI:
10.1016/j.addbeh.2019.04.007

PMCID:
PMC6555398

PMID:
30981033

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Addict Behav

Abbreviation: Addict Behav

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Substance-Related Disorders

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Association of smartphone use with abnormal social jetlag among adolescents in Korea before and aft…
Cho Y; In H; Park M and 2 more (2023) - Transparency Score: 3/6
Device and liquid characteristics used with sweet, menthol/mint, and tobacco ENDS liquid flavors: T…
Crespi E; Hardesty JJ; Nian Q and 4 more (2023) - Transparency Score: 3/6
A three-wave panel study on longitudinal relations between problematic social media use and psychol…
Di Blasi M; Salerno L; Albano G and 8 more (2022) - Transparency Score: 4/6
Did the acute impact of the COVID-19 pandemic on drinking or nicotine use persist? Evidence from a …
Pelham WE; Yuksel D; Tapert SF and 11 more (2022) - Transparency Score: 4/6
Factors associated with changes in flavored tobacco products used: Findings from wave 2 and wave 3 …
Bansal-Travers M; Rivard C; Silveira ML and 17 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest JB has received unrestricted research funding relating to smoking cessation from Pfizer, who manufacture smoking cessation medications. RW undertakes research and consultancy for and receives travel funds and hospitality from manufacturers of smoking cessation medications (Pfizer, GlaxoSmithKline and Johnson and Johnson). All authors declare no financial links with tobacco companies or e-cigarette manufacturers or their representatives."

Evidence found in paper:

"TAG Cancer Research UK; Cancer Research UK; NIHR Oxford Biomedical Research Centre; CLAHRC; UCL Ethics Committee"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025